Key result
NICE guidelines on myocardial revascularisation exhibit subtle differences from other international guidelines due to evidence base timing, healthcare system design, and cost-effectiveness models.
Why the study?
UK cardiologists use NICE and ESC guidelines for clinical decisions, but subtle differences exist between NICE recommendations on myocardial revascularisation and other international guidelines.
This review highlights subtle differences between NICE and international guidelines on myocardial revascularisation, driven by cost-effectiveness models and healthcare system variations.
These differences may influence UK revascularisation decisions; leaves open the need for updated cross-guideline harmonization research.
Cardiologists in the UK predominantly use the National Institute for Health and Care Excellence (NICE) and European Society of Cardiology guidelines to help guide decision-making. This article will appraise the current recommendations from NICE regarding myocardial revascularisation and compare them with other major international guidelines. While there are many similarities, subtle differences exist. These differences arise in part due to the evidence base at time of publication, as well as from the different healthcare systems that they are designed for, and from the cost-effectiveness models that dominate the methodology used by NICE. The clinical implications of the differences between the international guidelines will be analysed.
No takes yet. Share an insight, caveat, or question.
Jabbour et al. (2023) conducted a review in Myocardial revascularisation. NICE guidelines on myocardial revascularisation vs. Other major international guidelines was evaluated. NICE guidelines on myocardial revascularisation exhibit subtle differences from other international guidelines due to evidence base timing, healthcare system design, and cost-effectiveness models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: